Testing services

PCR infection testing

Molecular panels for urinary, wound, respiratory, gastrointestinal, STI, women’s health and nail infections, with antibiotic-resistance gene detection. Targets are identified directly from the specimen, without waiting for culture growth.

Testing areas

Target menus, accepted specimen types and collection requirements are provided by the laboratory during consultation.

UTI

Indication
Urinary symptoms, or fever or other systemic signs without another likely source, where the clinician suspects a urinary source.
Clinical use
Organism and resistance-gene results to support antimicrobial decisions while culture and clinical assessment proceed.
Discuss the UTI panel

Wound

Indication
Non-healing wounds and wounds with suspected infection.
Clinical use
Detection of targeted organisms and resistance genes to support treatment decisions alongside the clinical exam.
Discuss the wound panel

Respiratory

Indication
Symptomatic respiratory illness, including clusters of cases within a facility.
Clinical use
Identification of targeted pathogens to support isolation, cohorting and treatment decisions.
Discuss the respiratory panel

Gastrointestinal (GI)

Indication
Acute diarrheal illness, including suspected outbreaks on a unit.
Clinical use
Identification of targeted enteric pathogens to support infection-control measures and clinical management.
Discuss the GI panel

Nail fungal

Indication
Nail thickening or discoloration where onychomycosis is suspected.
Clinical use
Determines whether fungal organisms are detected before antifungal therapy, for dermatology and podiatry decisions.
Discuss the nail fungal panel

Women’s health

Indication
Vaginal symptoms with more than one possible cause.
Clinical use
Identification of organisms to support targeted therapy.
Discuss the women’s health panel

STI

Indication
Symptomatic patients and recommended sexually transmitted infection screening.
Clinical use
Identification of infections to support treatment and partner management.
Discuss the STI panel

Antibiotic resistance

Indication
Cases where resistance markers would inform antimicrobial selection.
Clinical use
Resistance-gene results, interpreted together with culture and susceptibility testing.
Discuss resistance testing

Interpretation and limitations

  • PCR detects genetic material. A positive result does not by itself establish symptomatic infection; colonization is possible.
  • A detected resistance gene does not by itself determine susceptibility or treatment, and an undetected gene does not prove susceptibility.
  • A negative result excludes only the targets on that panel.
  • When a specimen contains more than one organism, a resistance gene cannot be assigned to a specific organism.
  • Results are interpreted with culture and clinical assessment. Outside recommended screening, such as STI screening, testing is for symptomatic patients, ordered on clinical judgment.

Consult with the laboratory

A short consultation covers the panel, its specimen requirements and how results are reported to the ordering provider.

Request a consultation

Discuss a testing program with the laboratory

Review the panel that fits your patients, its specimen requirements, and how results and billing work.